Cargando…
Lenalidomide and the risk of serious infection in patients with multiple myeloma: a systematic review and meta-analysis
The immunomodulatory drug lenalidomide is highly effective against newly diagnosed and relapsed/refractory multiple myeloma (MM), but serious and even fatal infections have been associated with its use. In this meta-analysis, we assessed the overall risk of infection to MM patients treated with lena...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542295/ https://www.ncbi.nlm.nih.gov/pubmed/28423741 http://dx.doi.org/10.18632/oncotarget.16235 |